WO2019225754A1

WO2019225754A1 - Deodorant and inactivator

Info

Publication number: WO2019225754A1
Application number: PCT/JP2019/020759
Authority: WO
Inventors: 勇太間中; 山田　俊一; 薫森下; 雅子勝山; 落合　正敏; 明宏瓦谷; 裕香理桑原; 貴大石川
Original assignee: 株式会社資生堂; 高砂香料工業株式会社
Priority date: 2018-05-25
Filing date: 2019-05-24
Publication date: 2019-11-28
Also published as: TW202002938A; JPWO2019225754A1; CN112135602B; CN112135602A; JP2024020230A

Abstract

A deodorant and an inactivator which each contain at least one ingredient selected from among spearmint oil, lavandin oil, peppermint oil, l-citronellal, linalool, dihydromyrcenol, cis-3-hexenol, triplal, benzyl acetate, rosmarin oil, cis-3-hexcenyl acetate, lavender oil, (R)-3,7-dimethyl-6-octenenitrile, (1R,6S)-2,2,6-trimethylcyclohexanecarboxylic acid ethyl ester, eucalyptus oil, γ-undecalactone, rose oil, (R)-2-methyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol, (-)-isopulegol, etc.

Description

Deodorant and deactivator

Related applications

The present invention is based on the priority claim of Japanese patent application: Japanese Patent Application No. 2018-1005988 (filed on May 25, 2018), and the entire description of the application is incorporated herein by reference. Shall.

This disclosure relates to a deodorant that eliminates or reduces discomfort caused by body odor. The present disclosure relates to an inactivating agent that inactivates a physiological / psychological activity (modulation) action by a secretory component from a human body.

Many of the odors caused by odorous components emitted from human skin are unpleasant odors and are generally called “body odors”. For example, “aging odor” is known as a body odor peculiar to middle-aged and elderly people (see, for example, Patent Document 1). In order to eliminate the unpleasantness due to the aging odor, the aging odor suppressing fragrance composition described in Patent Document 1 has a component excellent in the masking effect on the aging odor and / or a component excellent in the harmony effect on the aging odor. It is blended.

In general, sulfur compounds are considered to be unpleasant odor components. Patent Document 2 discloses at least one selected from the group consisting of butyl 2-methylbutanoate, α-terpinene, dipentene, cis-4-heptenal, 1,4-cineole, trimethylhexylaldehyde, and (+)-limonene oxide. An inhibitor of the odor of a polysulfide compound is disclosed which contains as an active ingredient.

Japanese Patent Laid-Open No. 11-286428 WO2016 / 204212A1

The present inventors have noticed that there is a peculiar smell around a person who is in a tension state (stress state) in which the heart rate increases due to mental stress. Therefore, the present inventors have studied the cause of the odor. The odor is a body odor caused by a substance secreted / released from a person in a tension state or a mental stress state (hereinafter referred to as “tension” in this disclosure). Odor "or" stress odor ").

This tension odor is a sulfur-based odor that many people will feel uncomfortable. In recent years, interest in body odor has increased, and it is expected that demand for deodorants that can eliminate or reduce discomfort caused by tension odor will increase.

The odor suppressor described in Patent Document 2 refers only to bad odors other than the human body such as drain outlets and garbage, and has not been studied for bad odors emitted from the human body, and the odor described in Patent Document 2 It is unclear whether the suppressor can suppress the tension odor.

The present inventor believes that a component secreted and released from a person who is in a tension state or mental stress state (for example, a causative substance of a tension odor) has at least one of a physiologically active action and a psychologically active action. thinking. Therefore, inactivity that inactivates physiological activity and / or psychological activity by a component secreted from a person in tension and / or mental stress (hereinafter referred to as “tension odor component”). It is expected that demand for the agent will increase.

According to the first aspect of the present disclosure, <1> spearmint oil; <2> lavandin oil; <3> brackish oil; <4> l-citronellal; <5> linalool; <6> dihydromyrsenol; <7 <9> benzyl acetate; <10> rosmarin oil; <11> cis-3-hexenyl acetate; <12> lavender oil; <13> (R) -3,7 -Dimethyl-6-octenenitrile; <14> (1R, 6S) -2,2,6-trimethyl-cyclohexanecarboxylic acid ethyl ester; <15> eucalyptus oil; <16> γ-undecalactone; <17> roses <18> (R) -2-methyl-4- (2,2,3-trimethyl-3-cyclopenten-1-yl) -2-buten-1-ol; <19> (−)-isopulegol; <20> 2- (t-butyl) cyclohexyl acetate; <21> β-damacenone; <22> hexyl acetate; <23> l-cis-rose oxide; <24> 2-phenylethyl alcohol; <25> 3, 7 <Dimethyl-1-octanol; <26> Cedar oil; <27> Geranium oil; <28> 2-acetyl-2,3,8,8-tetramethyl-1,2,3,4,5,6,7 <29> l-citronellyl acetate; <30> geraniol; <31> 1-phenylethyl acetate; <32> (3S, 6E) -3,7,11-trimethyldodeca-6,10 <33> 2- (2-mercaptopropan-2-yl) -5-methylcyclohexanone; <34> terpineol; and a combination selected from the group consisting of: Kutomo containing one component, tension odor deodorizing agent.

According to the second aspect of the present disclosure, <1> spearmint oil; <2> lavandin oil; <3> brackish oil; <4> l-citronellal; <5> linalool; <6> dihydromyrsenol; <7 <9> benzyl acetate; <10> rosmarin oil; <11> cis-3-hexenyl acetate; <12> lavender oil; <13> (R) -3,7 -Dimethyl-6-octenenitrile; <14> (1R, 6S) -2,2,6-trimethyl-cyclohexanecarboxylic acid ethyl ester; <15> eucalyptus oil; <16> γ-undecalactone; <17> roses <18> (R) -2-methyl-4- (2,2,3-trimethyl-3-cyclopenten-1-yl) -2-buten-1-ol; <19> (−)-isopulegol; <20> 2- (t-butyl) cyclohexyl acetate; <21> β-damacenone; <22> hexyl acetate; <23> l-cis-rose oxide; <24> 2-phenylethyl alcohol; <25> 3, 7 <Dimethyl-1-octanol; <26> Cedar oil; <27> Geranium oil; <28> 2-acetyl-2,3,8,8-tetramethyl-1,2,3,4,5,6,7 <29> l-citronellyl acetate; <30> geraniol; <31> 1-phenylethyl acetate; <32> (3S, 6E) -3,7,11-trimethyldodeca-6,10 <33> 2- (2-mercaptopropan-2-yl) -5-methylcyclohexanone; <34> terpineol; and a combination selected from the group consisting of: Kutomo deactivators containing one ingredient. Inactivating agents inactivate the psychological and / or psychoactive activity of secretory components.

</ RTI> According to the deodorant of the present disclosure, it is possible to eliminate or reduce discomfort based on a tension odor.

According to the inactivating agent of the present disclosure, it is possible to inactivate or suppress the psychological or physiological activity action by the tension odor component.

10 is a graph showing the results in Example 5.

Favorable forms from the above viewpoints are described below.

According to a preferred form of the first aspect, the tension odor deodorant contains at least one of the above components <1> to <34> and combinations thereof as a masking agent for the tension odor.

According to a preferred form of the first aspect, the tension odor deodorant contains at least one of the above components <1> to <22> and combinations thereof as a harmonizing agent for the tension odor.

According to a preferred form of the first aspect, the strained deodorant contains at least one of the above components <1> to <22> and combinations thereof as a masking agent and a harmonicizing agent for the strained odor. .

According to a preferred form of the first aspect, the tension odor is an odor emitted from the body due to a tension state and / or mental stress.

According to a preferred form of the first aspect, the causative substance of the tension odor includes at least one of allyl mercaptan and dimethyl trisulfide.

According to a preferred form of the first aspect, the causative substance further contains at least one of dimethyl disulfide and methylpropyl trisulfide.

According to a preferred form of the first aspect, the causative substance further includes 1-octen-3-one.

According to a preferred form of the second aspect, the secretory component is a component secreted from the body due to tension and / or mental stress.

According to a preferred form of the second aspect, the secretory component contains at least one of allyl mercaptan and dimethyl trisulfide.

According to a preferred form of the second aspect, the secretory component further contains at least one of dimethyl disulfide and methylpropyl trisulfide.

According to a preferred form of the second aspect, the secretory component further contains 1-octen-3-one.

The deodorizer according to the first embodiment of the present disclosure will be described.

The deodorant of the present disclosure is a deodorant that can be suitably applied to body odor (tension odor) emitted when a person is in a tension state and / or a mental stress state. The deodorization referred to in the present disclosure is to prevent or mitigate a odor to be deodorized (hereinafter referred to as “bad odor”) by a sensory action. As the deodorizing action of the deodorant of the present disclosure, a masking action (masking effect) and a harmonizing action (harmonizing effect) can be considered. In the present disclosure, masking refers to competing with a good scent (aroma, fragrance) superior to the bad odor against the bad odor and relatively deodorizing (removing or mitigating the bad odor). In addition, in the present disclosure, harmonization refers to deodorizing odors by mixing odors that harmonize with bad odors and harmonizing odors as a whole (for example, converting bad odors into fragrances and fragrances). To resolve or alleviate).

The deodorizer of the present disclosure includes at least one of the following components as the first deodorant component:
<1> Spearmint oil; <2> Lavandin oil; <3> Brackish oil (peppermint oil); <4>l-citronellal;<5>linalool;<6> dihydromyrcenol (2,6- <7>cis-3-hexenol;<8> Tripral (dimethyl-3-cyclohexene-1-carbaldehyde); <9> benzyl acetate; <10> rosmarin oil (rose) <11> cis-3-hexenyl acetate; <12> lavender oil; <13> (R) -3,7-dimethyl-6-octenenitrile (commercially available products include, for example, LEVOCITRIE (registered trademark: Takasago International Corporation)); <14> (1R, 6S) -2,2,6-trimethyl-cyclohexanecarboxylic acid ethyl ester For example, THESARON (registered trademark: Takasago International Corporation)); <15> Eucalyptus oil; <16>γ-undecalactone;<17> Rose oil; <18> (R) -2-methyl-4- (2 , 2,3-Trimethyl-3-cyclopenten-1-yl) -2-buten-1-ol (commercially available products include, for example, HINDINOL (registered trademark: Takasago International Corporation)); <19> (-)- Isopulegol (commercially available product is, for example, COLACT (registered trademark: Takasago International Corporation) P); <20> 2- (t-butyl) cyclohexyl acetate (commercially available product is, for example, VERDOX (international flavor and Fragrance (IFF))); <21> β-Damacenone (1- (2-butenoyl) -2,6,6-trimethyl-1,3-cyclohexadiene) <22> Hexyl acetate; <23> l-cis-rose oxide ((2S, 4R) -tetrahydro-4-methyl-2- (2-methyl-1-propenyl) -2H-pyran); <24> 2- <25> 3,7-dimethyl-1-octanol (for example, DIHYDRO CITRONELLOL (Takasago International Corporation)); <26> Cedar oil; <27> Geranium oil; <28> 2 -Acetyl-2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalene (for example, ORBITONE (registered trademark: Takasago International Corporation) <29> l-citronellyl acetate; <30>geraniol;<31> 1-phenylethyl acetate; <32> (3S, 6E) -3,7,11-tri Chilledeca-6,10-dienal (commercially available products include, for example, BIOMUGUET (registered trademark: Takasago International Corporation)); <33> 2- (2-mercaptopropan-2-yl) -5-methylcyclohexanone (commercially available product) For example, RINGONOL (registered trademark: Takasago International Corporation) 50); <34>Terpineol;<35> Lime oil; <36> Orange peel oil; <37> Lemon oil; <38>Isoeugenol;<39<40>α-hexylcinnamaldehyde;<41> Cyclamenaldehyde (3- (4-isopropylphenyl) isobutyraldehyde); <42> 1- (5,5-dimethyl-1-cyclohexen-1-yl ) -4-Penten-1-one (commercially available products include, for example, DYNASCONE (registered trademark: <43> 3- (4-methoxyphenyl) -2-methylpropanal (commercially available products include, for example, CANTHOXAL (IFF)); <44> 1,1,2,3,3- Pentamethyl-6,7-dihydroindan-4 (5H) -one (commercially available products include, for example, CASHMERAN (IFF)); <45>trans-β-damascon;<46>trans-α-damascon;<47 Hexyl salicylate; <48> isocyclocitral (2,4,6-trimethyl-3-cyclohexene-1-carboxaldehyde); <49>α-amylcinnamaldehyde;<50> methyl 2-noninate; <51><52> Linalyl acetate; <53>Octanal;<54>Decanal;<55> Dodecanal <56> cis-3-hexen-1-yl salicylate; <57> allyl amyl glycolate; <58> methyl carbonate (Z) -3-hexenyl; <59> 5-methyl-3-heptanone oxime (commercially available product) For example, STEMONE (registered trademark: Givaudan)); <60> ethyl 2-tricyclo [5.2.1.02,6] decan-2-ylcarboxylate (commercially available products include, for example, FRUITATE ( <61> allyl hexanoate; <62> allyl cyclohexanepropionate; <63>anethole;<64>thymol;<65>cis-jasmon;<66>2'-acetonaphthone;<67>4-methoxytoluene;<68>p-anisaldehyde;<69>β-ionone;<70>coumarin;<71> cinnax Methyl; <72>maltol;<73> ethyl maltol; <74> isobutyl quinoline; <75> 2-isobutyl quinoline; and combinations thereof.

The deodorant of the present disclosure preferably contains at least one selected from the group consisting of the above components <1> to <37> and combinations thereof as a masking agent. When the deodorant of the present disclosure is a masking agent, from the viewpoint of masking effect, the above components <1> to <24>, <26>, <27>, <31>, and <35> to <37>, And at least one component selected from the group consisting of these combinations, and at least one component selected from the group consisting of the above components <1> to <6> and <35> and combinations thereof It is more preferable that it contains.

The deodorant of the present disclosure preferably contains at least one selected from the group consisting of the above components <1> to <22> and <35> to <37> and combinations thereof as a harmonizing agent. When the deodorant of the present disclosure is a harmonizing agent, from the viewpoint of the harmonizing effect, the components <1> to <19>, <35> to <37>, and combinations thereof are used. More preferably, it includes at least one selected component, and more preferably includes at least one component selected from the group consisting of the above components <1> to <18> and combinations thereof.

The deodorizer of the present disclosure can be used in combination with a masking action and a harmonicizing action. That is, the deodorizer of this indication can contain a masking agent and a harmonizing agent. In particular, the components <1> to <22> and <35> to <37>, and combinations thereof, have both a masking action and a harmonizing action, so that the tension odor can be effectively deodorized. .

The method for using the deodorant of the present disclosure and the method for preventing the tension odor will be described.

The deodorant of the present disclosure can be sprayed in the air in advance and / or after the event in a place where a tension odor is generated and / or a place where the tension odor may be generated. The deodorant can be attached to or spread on fabric products such as clothes, curtains and carpets in advance and / or after the fact. If the deodorant does not adversely affect the skin, the deodorant can be applied to the skin in advance and / or after the fact. For example, a deodorant can be applied to a place where a tension odor component is considered to be secreted, for example, palm, armpit, foot, back, head, face, oral cavity, and the like.

The deodorant of the present disclosure can be used in combination with other deodorants, those that remove or mitigate bad odors by chemical, biological, physical action and the like. For example, the deodorant of the present disclosure can further contain a deodorizing component, a deodorizing component, another deodorizing component, and the like as long as the effect of the deodorant of the present disclosure is not impaired.

The deodorant of the present disclosure can eliminate or alleviate discomfort that occurs when smelling a tension odor. In addition, a person who is or has been in a tension state or mental stress state, or a person who is likely to become a tension state or mental stress state in the future generates a tension odor by using the deodorant of the present disclosure. The anxiety that it may be present and the anxiety that it may generate a tense odor can be eliminated or reduced in advance and / or after the fact.

The deodorizer according to the second embodiment of the present disclosure will be described.

The deodorant according to the second embodiment may further contain a second deodorant component that physically and chemically deodorizes (deodorizes) the tension odor in addition to the deodorant according to the first embodiment. The second deodorizing component refers to a component that removes or mitigates (deodorizes) the bad odor by a chemical action and / or a physical action on the causative substance of the bad odor. In addition, even if the components listed in the present disclosure remove or mitigate malodors other than by chemical action and / or physical action, they do not fall outside the scope of the deodorant of the present disclosure.

The second deodorant component includes at least one of the first deodorant component and the second deodorant component.

The first deodorizing component can include at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Kamsnar extract, Lumpuyan extract, and combinations thereof. The first deodorant component is considered to be useful for deodorizing malodor caused by allyl mercaptan among causative substances of tension odor.

In the present disclosure, the silver-supported zeolite includes, for example, one in which at least a part of ion-exchangeable ions in the zeolite is replaced with silver ions. The silver ion content in the silver-supported zeolite can be, for example, 0.1% by mass to 15% by mass.

The second deodorant component is laponite, silver supported zeolite, zinc oxide, neem leaf extract, iris leaf extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, tocopherol, dibutylhydroxytoluene, sugarcane extract, loquat leaf It may comprise at least one selected from the second group consisting of extracts, green tea extracts, and combinations thereof. The second deodorizing component is considered to be useful for deodorizing malodor caused by dimethyl trisulfide, among substances causing tension odor.

The second deodorant component is (A) zinc oxide and (B) laponite, silver-supported zeolite, dibutylhydroxytoluene, sugarcane extract, loquat leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin , Sanna extract, green tea extract, and at least one selected from the third group consisting of combinations thereof. According to this combination, the deodorizing effect of the tension odor can be further enhanced.

Zinc oxide can be fine powder. The average particle diameter of zinc oxide can be, for example, 5 μm or less, 3 μm or less, 2 μm or less, 1 μm or less, or 0.5 μm or less.

The main components of the causative substance of the tension odor are allyl mercaptan and dimethyl trisulfide, as will be described later. Both substances have a particularly large impact on the sense of smell. Therefore, if the odors of allyl mercaptan and dimethyl trisulfide are eliminated, the tension odor can be effectively eliminated.

The second deodorizing component has a deodorizing effect on the tension odor. From this, according to the deodorizer which concerns on 2nd Embodiment, the deodorizing effect of a tension odor can further be heightened by combining a 1st deodorizing component and a 2nd deodorizing component.

A deactivation agent according to the third embodiment of the present disclosure will be described.

The tension odor component has at least one of a psychological activity and a physiological activity on humans. For example, when a person senses a tense odor, or when an olfactory receptor responds to a tense odor component, it becomes clear that the person is mentally fatigued, confused, or awakened. It's getting on. The tension odor component may have a psychoactive activity and / or psychological activity other than these. The inactivating agent of the present disclosure has an effect of inactivating such a mental activity and / or psychological activity of the tension odor component. That is, when a person senses the scent of the inactivation agent of the present disclosure, mixes and smells the scent of the inactivation agent and a tension odor, or when the olfactory receptor responds to the inactivation agent, etc. The person can eliminate or suppress the mental modulation and / or psychological modulation as described above.

Especially, it became clear that negative emotions increased when people perceived a tense odor. It also became clear that positive emotions tend to decline. Negative emotions include, for example, “anger / hostility”, “confused / embarrassed”, “depressed / depressed”, “fatigue / impotence”, and “tension / impotence” based on the POMS (Profile of Mood States) test. Anxiety ”is mentioned. It has been found that the tension odor particularly increases “confused / embarrassed”, “fatigue / apathy” and “tension / anxiety”. Positive emotions include, for example, “liveliness / energy” and “friendship”.

The inactive agent of the present disclosure includes at least one of the following components as a first inactivating component:
<1> Spearmint oil; <2> Lavandin oil; <3> Brackish oil; <4>1-citronellal;<5>Linalool;<6> Dihydromyrsenol (2,6-dimethyl-7- (7) cis-3-hexenol; <8> tripral (dimethyl-3-cyclohexene-1-carbaldehyde); <9> benzyl acetate; <10> rosmarin oil (rosemary oil); <11> cis-3-hexenyl acetate; <12> lavender oil; <13> (R) -3,7-dimethyl-6-octenenitrile (for example, LEVOCITRILE (registered trademark: Takasago International Corporation) <14> (1R, 6S) -2,2,6-trimethyl-cyclohexanecarboxylic acid ethyl ester (commercially available products include, for example, THES RON (registered trademark: Takasago International Corporation)); <15> Eucalyptus oil; <16>γ-undecalactone;<17> Rose oil; <18> (R) -2-methyl-4- (2,2 , 3-Trimethyl-3-cyclopenten-1-yl) -2-buten-1-ol (commercially available products include, for example, HINDINOL (registered trademark: Takasago International Corporation)); <19> (−)-isopulegol ( Examples of commercially available products include COLACT (registered trademark: Takasago International Corporation) P); <20> 2- (t-butyl) cyclohexyl acetate (commercially available products include, for example, VERDOX (International Flavor and Fragrance ( <21> β-Damacenone (1- (2-butenoyl) -2,6,6-trimethyl-1,3-cyclohexadiene); <22> Acetic acid hex <23> l-cis-rose oxide ((2S, 4R) -tetrahydro-4-methyl-2- (2-methyl-1-propenyl) -2H-pyran); <24> 2-phenylethyl alcohol; <25> 3,7-dimethyl-1-octanol (commercially available products include, for example, DIHYDRO CITRONELLOL (Takasago Kagaku Kogyo)); <26> Cedar oil; <27> Geranium oil; <28> 2-acetyl-2 , 3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalene (commercially available products include, for example, ORBITONE (registered trademark: Takasago International Corporation)); 29> l-citronellyl acetate; <30>geraniol;<31> 1-phenylethyl acetate; <32> (3S, 6E) -3,7,11-trimethyldodeca-6 0-dienal (commercially available products such as BIOMUGUET (registered trademark: Takasago International Corporation)); <33> 2- (2-mercaptopropan-2-yl) -5-methylcyclohexanone (commercially available products such as , RINGONOL (registered trademark: Takasago International Corporation) 50); <34>terpineol;<35> lime oil; <36> orange peel oil; <37> lemon oil; <38>isoeugenol;<39>phenylacetaldehyde;<40>α-hexylcinnamaldehyde;<41> Cyclamenaldehyde (3- (4-isopropylphenyl) isobutyraldehyde); <42> 1- (5,5-dimethyl-1-cyclohexen-1-yl) -4- Penten-1-one (commercially available products include, for example, DYNASCONE (registered trademark: Filmmenitzhi) <43> 3- (4-Methoxyphenyl) -2-methylpropanal (commercially available, for example, CANTHOXAL (IFF)); <44> 1,1,2,3,3-pentamethyl-6 , 7-Dihydroindan-4 (5H) -one (commercially available products include, for example, CASHMERAN (IFF)); <45>trans-β-damascone;<46>trans-α-damascone;<47> hexyl salicylate <48> isocyclocitral (2,4,6-trimethyl-3-cyclohexene-1-carboxaldehyde); <49>α-amylcinnamaldehyde;<50> methyl 2-noninate; <51> methyl anthranilate; <52> linalyl acetate; <53>octanal;<54>decanal;<55>dodecanal;<56> salicyl cis-3-hexen-1-yl; <57> allyl amyl glycolate; <58> methyl carbonate (Z) -3-hexenyl; <59> 5-methyl-3-heptanone oxime. (60) Ethyl 2-tricyclo [5.2.1.02,6] decan-2-ylcarboxylate (commercially available products include, for example, FRUITATE (registered trademark: Kao). <61> Allyl hexanoate; <62> Allyl cyclohexanepropionate; <63>Anethole;<64>Thymol;<65>cis-jasmon;<66>2'-acetonaphthone;<67> 4-methoxy <68>p-anisaldehyde;<69>β-ionone;<70>coumarin;<71> methyl cinnamate; <72>Rutoru;<73> ethyl maltol; <74> isobutyl quinoline; <75> 2-isobutyl quinoline; and combinations thereof.

From the viewpoint of the inactivating agent and inactivating action of the present disclosure, it is preferable to include at least one selected from the group consisting of the above components <1> to <37> and combinations thereof, and the above component <1> More preferably, it includes at least one component selected from the group consisting of <24>, <26>, <27>, <31>, and <35> to <37>, and combinations thereof. More preferably, it includes at least one component selected from the group consisting of 1> to <6> and <35>, and combinations thereof.

Psychologically active and physiologically active effects due to the tension odor component, and inactivation of the tension odor component due to the inactive agent are, for example, a method using a psychological questionnaire such as POMS (registered trademark) (Profile of Mood States). ), GACL (General Activity Checklist) or the like.

The method for using the deactivating agent of the present disclosure and the method for deactivating the tension odor component will be described.

The inactivating agent of the present disclosure can be sprayed in the air in advance and / or after the event in a place where a tension odor component is generated and / or a place where it may be generated. The deactivator can also be applied or spread on fabric products such as clothes, curtains and carpets in advance and / or after the fact. If the deactivator does not adversely affect the skin, the deactivator can be applied to the skin in advance and / or after the fact. For example, a deodorant can be applied to a place where a tension odor component is considered to be secreted, for example, palm, armpit, foot, back, head, face, oral cavity, and the like.

The inactivating agent of the present disclosure can be used in combination with other psychological and physiological action inactivating agents and the like. For example, the inactivation agent of the present disclosure may further contain another inactivation agent as long as the effect of the inactivation agent of the present disclosure is not inhibited. Other deactivators include, for example, those that remove or mitigate malodors by chemical, biological, physical action, etc. against malodors (eg, tension odors) (eg, deodorant components, deodorant components, deodorant components) Etc.).

The inactivating agent of the present disclosure can inactivate the mental activity and / or psychological activity of the tension odor component. Thereby, psychological modulation, physiological modulation, and the like caused by the tension odor component can be eliminated or suppressed. Persons who are or have been in tension or mental stress, or who are likely to become tension or mental stress, in advance and / or after using the inactivating agent of the present disclosure It is possible to take measures such as psychological modulation and physiological modulation.

The deactivating agent according to the fourth embodiment of the present disclosure will be described.

The deactivating agent according to the fourth embodiment further includes at least one of the second deactivating component and the third deactivating component in addition to the deactivating agent according to the third embodiment.

The second deactivating component can include at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Kamsnar extract, Lumpuyan extract, and combinations thereof. The first inactivating component is considered to be useful for inactivating malodor caused by allyl mercaptan among causative substances of tension odor.

The third inactivating component is laponite, silver supported zeolite, zinc oxide, neem leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, tocopherol, dibutylhydroxytoluene, sugarcane extract, loquat At least one selected from the second group consisting of leaf extract, green tea extract, and combinations thereof may be included. The second inactivating component is considered to be useful for inactivating malodor caused by dimethyl trisulfide, among the causative substances of tension odor.

The third inactivating component is (A) zinc oxide, (B) laponite, silver-supported zeolite, dibutylhydroxytoluene, sugarcane extract, loquat leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclo Preferably, at least one selected from a third group consisting of dextrin, sanna extract, green tea extract, and combinations thereof. According to this combination, the tension odor inactivating effect can be further enhanced.

The main components of the causative substance of the tension odor are allyl mercaptan and dimethyl trisulfide, as will be described later. Both substances have a particularly large impact on the sense of smell. Therefore, if the odors of allyl mercaptan and dimethyl trisulfide are eliminated, the psychological and / or physiologically active action due to the tension odor can be effectively inactivated.

The deactivating agent according to the fourth embodiment contains a second deactivating component and / or a third deactivating component having an action different from that of the first deactivating component. It is possible to further inactivate the mental activity and / or the psychological activity by the component.

The method for producing the deodorant and the deactivator of the present disclosure is not particularly limited. For example, a deodorant and an inactivating agent can be produced by mixing deodorant components.

The tension odor and the tension odor component referred to in the present disclosure will be described.

¡Tension odor is an odor emitted from the body when nervous or under stress. The tension or mental stress here includes, for example, tension or stress that depends on interpersonal relationships. Interpersonal tension / stress is, for example, the tension / stress that is being announced in public (especially before a large number of people), the tension / stress that is undergoing an important or oppressive interview Etc. In such a mental stress state, for example, when there is no heart rate increase due to exercise, the heart rate per minute is 20 bpm (beats per minute) or more, preferably 30 bpm or more higher than that at normal rest. It can be said that it is in a state. Normal resting means resting without mental stress and a state in which heart rate does not fluctuate, for example, a state of sitting and relaxing for a predetermined time or longer.

The tension odor is considered to be based on the components contained in the blood. In the present disclosure, “generation from the body (secretion / release)” means generation (secretion / release) from the skin, mucous membrane and / or oral cavity. “Body odor” in the present disclosure includes bad breath.

The tension odor component includes a compound containing sulfur element (sulfur compound). Examples of the sulfur compound include at least one of allyl mercaptan and dimethyl trisulfide. Preferably, the tension odor component includes both allyl mercaptan and dimethyl trisulfide.

The allyl mercaptan can be 0.1 ppb or more, 0.3 ppb or more, 0.5 ppb or more, 1 ppb or more, or 10 ppb or more on a volume basis. The allyl mercaptan can be 1,000 ppm or less, 100 ppm or less, 10 ppm or less, 1 ppm or less, 500 ppb or less, 100 ppb or less, or 10 ppb or less on a volume basis.

Dimethyl trisulfide can be 1 ppb or more, 2 ppb or more, 3 ppb or more, 5 ppb or more, 10 ppb or more, 20 ppb or more, 50 ppb or more, or 100 ppb or more on a volume basis. Dimethyl trisulfide can be 10,000 ppm or less, 1,000 ppm or less, 100 ppm or less, 10 ppm or less, 1 ppm or less, 100 ppb or less, or 10 ppb or less on a volume basis.

In the tension odor component, the mass ratio of allyl mercaptan to dimethyl trisulfide is, for example, 2 parts by mass or more, 5 parts by mass or more, 10 parts by mass or more, or 15 parts by mass with respect to 1 part by mass of allyl mercaptan. Part or more. The mass ratio of allyl mercaptan and dimethyl trisulfide is, for example, 50 parts by mass or less, 40 parts by mass or less, 30 parts by mass or less, or 25 parts by mass or less with respect to 1 part by mass of allyl mercaptan. Can do.

Tension odor components include hydrogen sulfide, methyl mercaptan, carbon disulfide, dimethyl sulfide, dimethyl disulfide, methylpropyl trisulfide, and these as sulfur compounds other than allyl mercaptan and dimethyl trisulfide (hereinafter referred to as “other sulfur compounds”). It may further contain at least one compound selected from the group consisting of: The total amount of sulfur compounds can be 0.1 ppb or more, 1 ppb or more, or 10 ppb or more on a volume basis. The total amount of sulfur compounds can be 10,000 ppm or less, or 1,000 ppm or less on a volume basis.

The tension odor component can contain 1-octen-3-one as a non-sulfur compound in addition to or alone with respect to the sulfur compound. 1-octen-3-one can be, for example, 0.1 ppb or more, 0.5 ppb or more, 1 ppb or more, 10 ppb or more, 100 ppb or more, or 1 ppm or more on a volume basis. 1-octen-3-one can be, for example, 1,000 ppm or less, 100 ppm or less, 10 ppm or less, or 1 ppm or less on a volume basis.

The deodorant and deactivator of the present disclosure will be described below with examples. However, the deodorant and the deactivator of the present disclosure are not limited to the following examples.

[Example 1: Masking test and Harmonizing test]
The tension odor component shown in Table 1 was dissolved in medium chain fatty acid to prepare a medium chain fatty acid solution of tension odor. Next, 10 μL of the deodorant (deactivator) shown in Table 2 and Table 3 is blended as a first deodorant component (first inactivating component) in 100 μL of this tension odor medium chain fatty acid solution, A test solution of deodorant was prepared. Next, each test solution was impregnated into a 2 cm square filter paper. Next, the filter paper was put into a disposable beaker having a capacity of 500 mL, and the beaker was sealed with aluminum foil. 30 minutes after sealing, a hole having a diameter of about 1 cm was formed in the aluminum foil. Seventeen specialized panels consisting of perfumers and evaluators smelled from the holes, and sensory evaluation of the masking effect and the harmonizing effect against the tension odor by each deodorant was performed according to the following criteria. Tables 2 and 3 show the average evaluation scores of 17 expert panels.

[Sensory score for masking effect]
3 points: The tension odor is masked very well;
2 points: The tension odor is well masked;
1 point: The tension odor is slightly masked;
0 point: The tension odor is not masked.

[Sensory score of harmony effect]
1 point: tension odor and deodorant are in harmony;
0 point: It cannot be said that tension odor and deodorant are harmonized or not harmonized;
-1 point: tension odor and deodorant are not in harmony.

The deodorizers of Test Examples 1 to 37 had a masking effect score of 1.5 or more, and were found to be effective in mitigating the tension odor. In particular, a deodorant having a score of 2 or more, preferably 2.5 or more has a high masking effect against a tension odor.

The deodorizers of Test Examples 1 to 22 and 35 to 37 had a score of 0.5 or more with respect to the harmonizing effect, and were found to be effective in reducing discomfort due to a tension odor. In particular, a deodorant having a score of 0.6 or more, preferably 0.7 or more has a high harmonizing effect against the tension odor.

Further, the deodorizers of Test Examples 1 to 22 and 35 to 37 have both a masking effect and a harmonizing effect. Therefore, the deodorizers of Test Examples 1 to 22 and 35 to 37 could remarkably reduce discomfort due to the tension odor or eliminate the tension odor due to both effects. In particular, a deodorant having a masking effect score of 2.5 or more and a harmony effect score of 0.6 or more was useful for deodorizing tension odors.

[Example 2: Deodorization test for dimethyl trisulfide]
Deodorant solution 0.05% by mass and dipropylene glycol 99.95% by mass are mixed as a second deodorant component (second inactivation component), and a deodorant solution is prepared for each deodorant. did. 1 mL of the deodorant solution and 5 × 10 ⁻⁴ parts by mass of dimethyl trisulfide with respect to 1 part by mass of the deodorant were injected into a sample tube having a capacity of 30 mL. Three expert panels sniffed the scent in the sample tube and evaluated the deodorizing effect of each deodorant on dimethyltrisulfide according to the following criteria.

[Deodorizing effect on substances causing tension odor]
2 points: Special panel evaluated that deodorant has high deodorizing effect;
1 point: A special panel evaluated that the deodorant has a slightly higher deodorizing effect;
0 point: The expert panel evaluated that there was no deodorant effect of a deodorizer.

Table 4 shows the deodorant tested and the evaluation of the deodorizing effect of each deodorant by a specialized panel. The evaluation shown in Table 4 represents the average score of the specialized panel according to the following criteria. The average particle size of zinc oxide used in the following examples is about 0.2 μm.

A: 2 points;
B: 1.5 points or more and less than 2 points;
C: 1 point or more and less than 1.5 point;
D: Less than 1 point.

The deodorizers of Test Examples 51 to 55 were confirmed to have a deodorizing effect on dimethyl trisulfide, which is a causative substance of tension odor. Therefore, the deodorizers of Test Examples 51 to 55 are considered effective for deodorizing tension odors.

[Example 3: Deodorization test for allyl mercaptan]
Deodorant as a second deodorant component (second inactivating component) 0.10% by mass and dipropylene glycol 99.90% by mass are mixed, and a deodorant solution is added to each deodorant. Produced. 1 mL of the deodorant solution and 5 × 10 ⁻⁶ parts by mass of allyl mercaptan with respect to 1 part by mass of the deodorant were injected into a 30 mL sample tube. Three expert panels sniffed the scent in the sample tube, and evaluated the deodorizing effect of each deodorant on allyl mercaptan according to the following criteria. Table 5 shows the deodorant tested, and the evaluation of the deodorizing effect by a specialized panel for each deodorant. The evaluation criteria are the same as in Example 2.

The deodorizers of Test Examples 60 to 68 were confirmed to have a deodorizing effect on allyl mercaptan, which is a causative substance of tension odor. Therefore, the deodorizers of Test Examples 60 to 68 are considered to be effective for deodorizing tension odors.

[Example 4: Deodorization test for allyl mercaptan]
Deodorant as a second deodorant component (second inactivating component) 0.10% by mass and dipropylene glycol 99.90% by mass are mixed, and a deodorant solution is added to each deodorant. Produced. The deodorizer contains 50% by mass of zinc oxide as component A and 50% by mass of component B shown in Table 3. 1 mL of the deodorant solution and 2.5 × 10 ⁻⁶ parts by mass of allyl mercaptan with respect to 1 part by mass of the deodorant were injected into a 30 mL sample tube. Three expert panels sniffed the scent in the sample tube, and evaluated the deodorizing effect of each deodorant on allyl mercaptan according to the following criteria. Table 6 shows the deodorant tested, and the evaluation of the deodorizing effect by a specialized panel for each deodorant. The evaluation criteria are the same as in Example 2.

When zinc oxide and other deodorant were mixed, the deodorizing effect was generally improved as compared with using the deodorant component alone. For example, when the test examples 60, 66, 72, 73, and 75 shown in Table 2 are compared with the test examples 76, 82, 87, 88, and 90 shown in Table 3, respectively, the deodorization used in Example 2 is compared. By adding zinc oxide to the agent, the deodorizing effect could be enhanced compared to the deodorant alone. For example, laponite, hydroxypropyl-β-dextrin, sugarcane extract, loquat leaf extract, and green tea extract alone had a low deodorizing effect, but the deodorizing effect could be enhanced by mixing with zinc oxide. That is, these deodorizing components and zinc oxide are considered to have a synergistic effect of deodorization. From this, it is thought that mixing of a plurality of types of deodorizing components is more effective for deodorizing tension odors. In particular, a deodorant containing zinc oxide as the second deodorant component is considered to be more effective for deodorizing tension odors.

When comparing Test Example 62 and Test Example 78, the deodorizing effect could be enhanced by increasing the amount of zinc oxide with respect to the malodor-causing substance. From this, if the application amount of a deodorizer is increased with respect to a tension odor, the deodorizing effect can be improved more.

[Example 5: Psychological / mental effect test]
The subject was sniffed with a tension odor model composition, and the psychological and mental changes of the subject due to the tension odor were confirmed using POMS (registered trademark) and GACL. As a result, it was confirmed that when the subject smells a tense odor, arousal, fatigue and confusion occur.

Next, when the deodorant of the present disclosure was sniffed together with the model composition of tension odor, the subject did not see the psychological and mental changes described above. From this, it was confirmed that the deodorizer of this indication can inactivate the psychological and mental action by a tension odor (secretory component).

The following is a detailed description of a test that analyzed psychological state changes using the POMS (registered trademark) 2 adult shortened version (Profile of Mood, States, Second Edition, Adult, and Short) Japanese test paper. In this psychological analysis, based on the answers to the questions, anger / hostility, confusion / embarrassment, depression / depression, fatigue / apathy, and tension / anxiety, which are negative mood indicators, In addition, it is possible to confirm the psychological state related to “liveness / vibration” and “friendship” which are positive mood indexes. There were five questions for each index on the test paper, and each subject was given a score according to the following criteria for the mood presented in each question (maximum score of 20 for each index).

0 points: no mood presented;
1 point: There was a little feeling presented;
2 points: The mood presented was ok;
3 points: There was a lot of feeling presented;
4 points: The feelings presented were very much.

First, eight subjects were in a resting state for 20 minutes. After that, I was asked to answer the question on the above inspection sheet. This inspection is referred to as “inspection 1”.

Next, among the strained odor model compositions shown in Table 7, each subject continued to sniff the strained odor for 5 minutes using the lowest concentration model composition that could be recognized by each subject. After that, he asked me to answer the same question as in Exam 1. This inspection is referred to as “inspection 2”.

Next, “Inspection 3” was performed on a different day from Inspection 1 and Inspection 2. In the examination 3, first, the subject who carried out the examination 1 and the examination 2 was in a resting state for 20 minutes in the same manner as the examination 1. Next, each subject continued to sniff a sample gas in which 10 μL of a deodorant having the composition shown in Table 8 was mixed with 100 μL of the tension odor model composition used in Test 2, for 5 minutes. After that, he asked me to answer the same question as in Exam 1.

The average value and standard deviation of the scores for each index in the examinations 1 to 3 were calculated. Table 9 shows the results. In FIG. 1, the graph of the average value of a score with respect to each parameter | index and a standard deviation is shown.

Comparing the results of Test 1 and Test 2, as shown in FIG. 1, it was found that negative emotions, particularly tension, confusion, and fatigue, increase by perceiving a tension odor. On the other hand, there was a tendency for positive emotions to decline. From this, it was found that the tense odor has a psychological and mental action that turns human emotions in an unstable direction.

On the other hand, when tests 1 to 3 were compared, it was found that when the deodorant of the present disclosure was applied to the tension odor, negative emotions due to the tension odor did not increase. Also, positive emotions did not decline. The score of Test 3 to which the deodorant of the present disclosure was applied was equivalent to the score in the rest state of Test 1. From this, it was found that the deodorant of the present disclosure can inactivate (eliminate, reduce, and / or alleviate) the psychological and mental effects of a tension odor.

When the mixed gas of the tension odor model composition used in Inspection 3 and the deodorant of the present disclosure was directly mass analyzed, each component of the tension odor model composition was detected. From this, it is considered that the negative emotion caused by the tension odor in Test 3 did not increase because the subject did not perceive or recognize the tension odor with the deodorant of the present disclosure. From this, it was found that even if a tension odor exists, if the tension odor can be deodorized by the masking action and / or the harmonizing action, the psychological and mental effects caused by the tension odor can be inactivated. That is, it was found that the deodorant of the present disclosure can be applied as an inactivating agent for psychological and mental effects caused by a tension odor.

Some or all of the above embodiments may be described as in the following supplementary notes, but are not limited to the following descriptions. Each supplementary note can be combined with each claim recited in the claims.

[Appendix 1]
Including at least one of a first deodorant component and a second deodorant component;
The first deodorizing component includes at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Camsnar extract, Lumpuyan extract, and combinations thereof;
The second deodorant component is composed of laponite, silver supported zeolite, zinc oxide, neem leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, tocopherol, and combinations thereof. A tension odor deodorant comprising at least one selected from the group of:

[Appendix 2]
Including at least one of a first deodorant component and a second deodorant component;
The first deodorizing component includes at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Camsnar extract, Lumpuyan extract, and combinations thereof;
The second deodorant component is
Zinc oxide,
Selected from the third group consisting of laponite, silver supported zeolite, dibutylhydroxytoluene, sugarcane extract, loquat leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, green tea extract, and combinations thereof A deodorant with tension.

[Appendix 3]
Including at least one of a first deactivating component and a second deactivating component;
The first deactivating component includes at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Kamsnar extract, Lumpuyan extract, and combinations thereof;
The second inactivating component includes laponite, silver-supported zeolite, zinc oxide, neem leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, tocopherol, and combinations thereof. Comprising at least one selected from the group of two;
An inactivating agent that inactivates the psychological or mental activity of secretory components.

[Appendix 4]
Including at least one of a first deactivating component and a second deactivating component;
The first deactivating component is at least one selected from the first group consisting of silver-supported zeolite, tocopherol, zinc oxide, Kamsnar extract, Lumpuyan extract, and combinations thereof;
The second inactivating component is
Zinc oxide,
Selected from the third group consisting of laponite, silver supported zeolite, dibutylhydroxytoluene, sugarcane extract, loquat leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-cyclodextrin, sanna extract, green tea extract, and combinations thereof At least one of
An inactivating agent that inactivates the psychological or mental activity of secretory components.

Although the deodorizer and the deactivator of the present disclosure have been described based on the above-described embodiments and examples, the present invention is not limited to the above-described embodiments and examples, and is within the scope of the present invention. Based on the basic technical idea, various disclosed elements (including elements described in the claims, the specification, and the drawings) can include various modifications, changes, and improvements. In addition, various combinations, substitutions, or selections of the disclosed elements are possible within the scope of the claims of the present invention.

Further problems, objects, and forms (including modified forms) of the present invention will become apparent from the entire disclosure of the present invention including the claims.

The numerical ranges described in this document should be construed as any specific numerical value or range included in the said range, even if not otherwise specified.

Claims

<1> Spearmint oil; <2> Lavandin oil; <3> Hack oil; <4> l-citronellal; <5> linalool; <6> dihydromyrsenol; <7> cis-3-hexenol; <8> <9> benzyl acetate; <10> rosmarin oil; <11> cis-3-hexenyl acetate; <12> lavender oil; <13> (R) -3,7-dimethyl-6-octenenitrile; <14 (1R, 6S) -2,2,6-trimethyl-cyclohexanecarboxylic acid ethyl ester; <15> Eucalyptus oil; <16> γ-undecalactone; <17> Rose oil; <18> (R) -2 -Methyl-4- (2,2,3-trimethyl-3-cyclopenten-1-yl) -2-buten-1-ol; <19> (-)-isopulegol; <20> 2- (t-butyl acetate) <21> β-Damasenone; <22> Hexyl acetate; <23> l-cis-rose oxide; <24> 2-phenylethyl alcohol; <25> 3,7-dimethyl-1-octanol; <26 <27> Geranium oil; <28> 2-acetyl-2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalene; <29 <31> geraniol; <31> 1-phenylethyl acetate; <32> (3S, 6E) -3,7,11-trimethyldodeca-6,10-dienal; <33> 2- ( 2-mercaptopropan-2-yl) -5-methylcyclohexanone; <34> terpineol; and at least one component selected from the group consisting of these, Chonioi deodorant.
2. The tension odor deodorant according to claim 1, comprising at least one of the components <1> to <34> and a combination thereof as a masking agent for the tension odor.
2. The tension odor deodorant according to claim 1, comprising at least one of the components <1> to <22> and a combination thereof as a harmonizing agent for the tension odor.
The tension odor deodorant according to any one of claims 1 to 3, comprising at least one of the components <1> to <22> and a combination thereof as a masking agent and a harmonicizing agent for the tension odor. Agent.
The tension odor deodorant according to any one of claims 1 to 4, wherein the tension odor is an odor emitted from the body due to a tension state and / or mental stress.
The tension odor deodorizer according to any one of claims 1 to 5, wherein the causative substance of the tension odor includes at least one of allyl mercaptan and dimethyl trisulfide.
The tension odor deodorant according to claim 6, wherein the causative substance further contains at least one of dimethyl disulfide and methylpropyl trisulfide.
The tension odor deodorant according to claim 6 or 7, wherein the causative substance further contains 1-octen-3-one.
<1> Spearmint oil; <2> Lavandin oil; <3> Hack oil; <4>l-citronellal;<5>linalool;<6>dihydromyrcenol;<7>cis-3-hexenol;<8><9> benzyl acetate; <10> rosmarin oil; <11> cis-3-hexenyl acetate; <12> lavender oil; <13> (R) -3,7-dimethyl-6-octenenitrile; <14 (1R, 6S) -2,2,6-trimethyl-cyclohexanecarboxylic acid ethyl ester; <15> Eucalyptus oil; <16>γ-undecalactone;<17> Rose oil; <18> (R) -2 -Methyl-4- (2,2,3-trimethyl-3-cyclopenten-1-yl) -2-buten-1-ol; <19>(-)-isopulegol;<20> 2- (t-butyl acetate) <21>β-Damasenone;<22> Hexyl acetate; <23> l-cis-rose oxide; <24> 2-phenylethyl alcohol; <25>3,7-dimethyl-1-octanol;<26><27> Geranium oil; <28>2-acetyl-2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalene;<29><30>geraniol;<31> 1-phenylethyl acetate; <32> (3S, 6E) -3,7,11-trimethyldodeca-6,10-dienal; <33> 2- (2 -At least one component selected from the group consisting of -mercaptopropan-2-yl) -5-methylcyclohexanone; <34>terpineol; and combinations thereof;
An inactivating agent that inactivates the psychological and / or psychoactive activity of the secretory component.
The inactivating agent according to claim 9, wherein the secretory component is a component secreted from the body due to tension and / or mental stress.
The inactivating agent according to claim 9 or 10, wherein the secretory component contains at least one of allyl mercaptan and dimethyl trisulfide.
The tension odor deodorant according to claim 11, wherein the secretory component further contains at least one of dimethyl disulfide and methylpropyl trisulfide.
The inactivating agent according to claim 11 or 12, wherein the secretory component further comprises 1-octen-3-one.